Success Metrics

Clinical Success Rate
100.0%

Based on 32 completed trials

Completion Rate
100%(32/32)
Active Trials
0(0%)
Results Posted
78%(25 trials)

Phase Distribution

Ph phase_4
4
13%
Ph not_applicable
2
6%
Ph phase_1
7
22%
Ph phase_3
17
53%
Ph phase_2
2
6%

Phase Distribution

7

Early Stage

2

Mid Stage

21

Late Stage

Phase Distribution32 total trials
Phase 1Safety & dosage
7(21.9%)
Phase 2Efficacy & side effects
2(6.3%)
Phase 3Large-scale testing
17(53.1%)
Phase 4Post-market surveillance
4(12.5%)
N/ANon-phased studies
2(6.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

32 of 32 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

32

all time

Status Distribution
Completed(32)

Detailed Status

Completed32

Development Timeline

Analytics

Development Status

Total Trials
32
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 17 (21.9%)
Phase 22 (6.3%)
Phase 317 (53.1%)
Phase 44 (12.5%)
N/A2 (6.3%)

Trials by Status

completed32100%

Recent Activity

0 active trials
Showing 5 of 32
completedphase_4

Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)

NCT01131182
completednot_applicable

Incretin Effect in People With Impaired Fasting Glucose

NCT00795275
completednot_applicable

Treatment of Diabetes After Gastric Bypass With Sitagliptin

NCT01512797
completedphase_3

Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)

NCT01177384
completedphase_3

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

NCT01189890
View all 32 trials

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT01131182Phase 4

Study of Sitagliptin Treatment in Patients With Type 2 Diabetes During Ramadan (0431-263)

Completed
NCT00795275Not Applicable

Incretin Effect in People With Impaired Fasting Glucose

Completed
NCT01512797Not Applicable

Treatment of Diabetes After Gastric Bypass With Sitagliptin

Completed
NCT01177384Phase 3

Clinical Trial to Evaluate the Safety and Efficacy of the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus Receiving Acarbose Monotherapy (MK-0431-130)

Completed
NCT01189890Phase 3

Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)

Completed
NCT01076075Phase 3

A Study to Evaluate the Safety and Efficacy of Sitagliptin 100 mg in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control (MK-0431-229)

Completed
NCT01034111Phase 3

A Local Experiential Study With Sitagliptin (an Antihyperglycemic Drug) in 30 Patients With Type 2 Diabetes Mellitus (0431-178)

Completed
NCT00832390Phase 4

Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)

Completed
NCT00875394Phase 3

Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)

Completed
NCT00830076Phase 1

A Study of the Effects of Co-Administration of Sitagliptin (MK-0431) and Metformin on Incretin Hormone Concentrations (MK-0431-110)

Completed
NCT00833027Phase 4

ALPHA Sitagliptin Add on to Metformin (0431-103)

Completed
NCT00730275Phase 1

A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents (0431-081)

Completed
NCT00541229Phase 1

Sitagliptin Dose Comparison Study in Patients With Type 2 Diabetes (MK-0431-077)(COMPLETED)

Completed
NCT00395343Phase 3

Sitagliptin Added-on to Insulin Study (0431-051)

Completed
NCT00722371Phase 3

MK0431 and Pioglitazone Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-102 AM2)

Completed
NCT00372060Phase 3

MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)

Completed
NCT00545584Phase 3

Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)

Completed
NCT00449930Phase 3

Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)

Completed
NCT00305604Phase 3

Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)

Completed
NCT00758069Phase 2

Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)

Completed

Drug Details

Intervention Type
DRUG
Total Trials
32